Arkolith/Insider Trading/ATNX/Form 4

Kwan Rudolf

EVP, Chief Medical OfficerAthenex, Inc. (ATNX) · full profile →Form 4 · filed Aug 15, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 12, 2022Grant(A)9K$0.52$5K300K
Aug 3, 2022Option exercise(M)18K——295K
Aug 3, 2022Tax withholding(F)4K$0.58$2K291K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 3, 2022Option exercise(M)18K—$053K

Transaction Codes

A
Grant / award
M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-045863) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML